- INICIO
-
Genéricos
Novedades
- FDA approves generic teriparatide and levetiracetam
- US generics launch and approval for Dr Reddy’s and Lupin
- Five Chinese companies join UN’s MPP for Covid-19 medicines
- South Korean companies to make generic Bridion and COVID-19 drugs
Investigación
- Japan’s drug shortage crisis: challenges and policy solutions
- Saudi FDA drug approvals and GMP inspections: trend analysis
- Generic medications in the Lebanese community: understanding and public perception
- Community pharmacists’ understanding of generic and biosimilar drugs: Lebanon case study
General
- Crecimiento de medicamentos genéricos en Brasil y Venezuela
- EMA launches European shortages monitoring platform to tackle persistent medicine shortages
- Penetración de los medicamentos genéricos en México y Brasil
- FDA releases one-year progress report for the Generic Drug Cluster
-
Biosimilares
Novedades
- EMA recommends approval for ranibizumab biosimilar Vislyfa
- FDA approves third interchangeable insulin glargine biosimilar Langlara
- EMA recommends approval for ranibizumab biosimilar Rexatilux
- Japan approves Samsung-Nipro’s ustekinumab biosimilar
Investigación
- Biosimilars uptake in Chile: why does it lags behind?
- La jeringa precargada del biosimilar de aflibercept (AVT06) promete inyecciones oculares más seguras y rápidas
- Un estudio de la OCDE no encuentra una relación directa entre las normas de publicidad y la adopción de biosimilares
- Alcanzar los objetivos ASG en el desarrollo farmacéutico
General
- Biosimilars approved in Europe
- La SBR publica un posicionamiento sobre la intercambiabilidad segura entre biológicos originales y biosimilares
- Biosimilars approved in the US
- Samsung Bioepis wins Pyzchiva case; Regeneron patent rulings threaten foreign biosimilars
- MORE EDITORIAL SECTIONS
- Search
